
Introduction Substance abuse is a public health problem resulting from the interaction between exposure, neuroadaptations, and genetic susceptibility. This review aimed to synthesize recent evidence on the genes and neurobiological systems involved in the development of substance abuse. Methods A literature review was conducted, primarily of articles published within the last 10 years. MEDLINE/PubMed, Scopus, Web of Science, ScienceDirect, and specialized genetic and biomedical information resources were consulted, yielding 158 references on the genetics of addiction, neurotransmission, neuroplasticity, and the use of alcohol, nicotine, cannabis, cocaine, and opioids were included. Results Addiction arises from the interaction between repeated exposure to substances of abuse, persistent neuroadaptations, and genetic susceptibility. The main neurobiological alterations involve the ventral tegmental area, nucleus accumbens, prefrontal cortex, amygdala, and hippocampus, with participation from the dopaminergic, glutamatergic, GABAergic, opioid, endocannabinoid, cholinergic, serotonergic, and noradrenergic systems. Genetic variants in and have been associated with susceptibility to developing substance use disorders. Furthermore, chronic exposure alters pathways such as cAMP/PKA, CREB, FosB, AP-1, and ERK, which promotes tolerance, dependence, sensitization, and relapse. However, most of the described variants contribute only to a limited extent to susceptibility to substance abuse, and their magnitude may differ depending on the substance, methodological differences between studies, and the type of population studied. Conclusions Susceptibility to addiction may arise from a complex interaction between genetic, neurobiological, and potentially environmental factors. However, larger functional, population-based, and multi-ethnic studies are needed to validate these associations and determine their usefulness in prevention, risk stratification, and personalized therapies.
Introduction Musculoskeletal symptoms are a public health concern because of their association with disability and increased economic burden. In other countries, people with these symptoms report lower physical activity levels, less sleep and more sedentary behavior. Evidence in Chile remains limited. Objective To analyze the association between musculoskeletal symptoms and physical activity, sedentary behavior, and sleep in the Chilean adult population. Methods A secondary analysis of the 2016 to 2017 Chilean National Health Survey (5472 adults), accounting for its complex sampling design. Musculoskeletal symptoms experienced during the previous seven days were assessed using the Community-Oriented Programme for the Control of Rheumatic Disease Core Questionnaire. Physical activity and sedentary behavior were assessed using the Global Physical Activity Questionnaire, while sleep duration was measured as the self-reported average number of hours per day. Differences in minutes per day were estimated with linear regression, while adherence to recommendations (World Health Organization physical activity guidelines, sedentary time of less than four hours per day, and sleep duration of seven to nine hours per day) was assessed using univariable and adjusted logistic regression models. Results Musculoskeletal symptoms were present in 38% (95% confidence interval 35 to 41) of adults. Compared to adults without symptoms, those with symptoms had mean differences of 16 minutes per day (95% confidence interval -8 to 40) in total physical activity, 16 minutes per day (95% confidence interval -1 to 33) in sedentary behavior, -16 minutes per day (95% confidence interval -25 to -7) in sleep, 28 minutes per day (95% confidence interval 8 to 49) in work physical activity and -12 minutes per day (95% confidence interval -22 to -3) in travel physical activity. Among adults with symptoms, 36%, 35%, and 48% did not meet the physical activity, sedentary, and sleep recommendations, respectively. No statistically significant associations were found between musculoskeletal symptoms and adherence to any of these recommendations. Conclusions Adults with musculoskeletal symptoms reported similar levels of total physical activity and sedentary behavior, about 16 fewer minutes of sleep per day, and more work-related physical activity than adults without symptoms. Failure to meet the recommendations was frequent in both groups. Given the cross-sectional study design, prospective studies are needed to clarify the direction of these associations.
Objective To adapt the Family APGAR (Adaptability, Partnership, Growth, Affection, Resolve) score to the Quechua language spoken in San Martín and evaluate its structural validity, reliability, convergent validity, and differential item functioning (DIF) among adults in the Peruvian Amazon. Methods After forward and backward translation (Spanish–Quechua of San Martín–Spanish), the Family APGAR underwent cultural adaptation through expert review and a focus group from the target population. In a non-probabilistic sample of 402 Quechua-speaking adults from San Martín, Peru, confirmatory factor analysis was conducted to assess factorial structure. Reliability was estimated using Cronbach’s alpha and McDonald’s omega coefficients. Differential item functioning was examined using purified MIMIC (Multiple Indicators Multiple Causes) models. Results The unidimensional model showed adequate fit (comparative fit index = 0.993; Tucker–Lewis index = 0.987; standardized root mean square residual = 0.044; root mean square error of approximation = 0.074), acceptable reliability (α = 0.78; ω = 0.79), and satisfactory convergent validity (average variance extracted = 0.52). Limited differential item functioning was identified: P4 showed differential item functioning by residence (β = 0.193; pBH < .001) and P3 by marital status (β = −0.117; pBH = .039), while no robust age-related differential item functioning was observed. Conclusions The Quechua version of the Family APGAR showed a unidimensional structure with adequate validity and reliability. Overall psychometric performance was satisfactory, although the identified item-level differential item functioning should be considered when interpreting scores across sociodemographic groups.
Introduction The Isapre system crisis, enrollee migration to the public insurer, and the expansion of complementary insurance have reshaped spending incentives in Fonasa’s free-choice modality. Whether the higher spending of insured beneficiaries reflects moral hazard or selection bias is unclear. Objectives To estimate, from the public payer’s perspective, the additional free-choice-modality spending attributable to holding complementary insurance, and to decompose it into selection bias and moral hazard, between 2022 and 2025. Methods Analytical observational study on individual-level administrative microdata (January 2022 to May 2025). Insurance was identified through its effective use. A counterfactual was built using nearest-neighbour (k = 1, without replacement) on observable covariates, and the classification error was corrected with a non-linear household-size decay model. The outcome was the percentage difference in FAM free-choice-modality spending per beneficiary, in inflation-indexed units. Results The crude per-capita spending gap was 57.6% higher among the insured; it fell to 44.2% after matching and converged to an average treatment effect on the treated of 30.2% (95% CI: 28.2 to 32.2%) after correcting the classification error, with annual estimates ranging from 28.8% to 31.3%. Conclusions The higher spending associated with complementary insurance reflects both risk selection and moral hazard; at least 13 percentage points are attributable to differences in the composition of the population purchasing complementary insurance. Complementary insurance is associated with an increase of approximately 30% in spending under the Free Choice Modality, after controlling for observable and classification biases.